Amedisys, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US0234361089
USD
100.99
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
621.86
594.78
598.05
587.67
591.19
571.41
570.79
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
621.86
594.78
598.05
587.67
591.19
571.41
570.79
Raw Material Cost
352.84
470.46
349.18
477.17
460.64
453.75
325.36
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
130.32
131.97
144.69
134.83
129.32
127.95
147.72
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
6.42
6.42
6.98
7.77
7.89
8.12
8.23
Selling and Distribution Expenses
196.28
6.22
202.70
6.73
7.83
7.43
197.04
Other Expenses
-13.67
-13.84
-15.17
-14.26
-13.72
-13.61
-15.60
Total Expenditure (Excl Depreciation)
549.12
476.69
551.88
483.90
468.47
461.19
522.40
Operating Profit (PBDIT) excl Other Income
72.69999999999999
118.10000000000001
46.2
103.80000000000001
122.69999999999999
110.19999999999999
48.4
Other Income
9.16
54.27
7.37
6.43
4.91
3.73
3.42
Operating Profit (PBDIT)
88.60
121.18
60.25
60.26
75.38
62.15
57.70
Interest
6.42
6.42
6.98
7.77
7.89
8.12
8.23
Exceptional Items
-27.16
-16.77
-65.79
-16.67
-11.90
-20.67
-14.38
Gross Profit (PBDT)
269.02
124.32
248.87
110.50
130.54
117.66
245.43
Depreciation
6.70
6.79
6.71
6.83
6.36
6.14
5.89
Profit Before Tax
48.33
91.20
-19.23
28.99
49.23
27.23
29.20
Tax
19.27
29.38
6.29
12.47
16.66
12.63
10.18
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
28.08
61.01
-20.38
16.91
32.30
14.40
19.32
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
28.08
61.01
-20.38
16.91
32.30
14.40
19.32
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.97
0.81
-5.14
-0.40
0.27
0.19
-0.30
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
29.05
61.82
-25.52
16.51
32.57
14.59
19.02
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
1,232.53
1,199.63
1,134.54
1,147.76
1,125.20
1,088.18
1,066.51
Earnings per share (EPS)
0.84
1.84
-0.62
0.51
0.98
0.44
0.59
Diluted Earnings per share
0.84
1.84
-0.62
0.51
0.98
0.44
0.59
Operating Profit Margin (Excl OI)
11.7%
10.11%
7.72%
8.0%
10.85%
9.15%
8.48%
Gross Profit Margin
8.85%
16.48%
-2.09%
6.1%
9.4%
5.84%
6.15%
PAT Margin
4.52%
10.26%
-3.41%
2.88%
5.46%
2.52%
3.39%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2025 is 4.56% vs -0.55% in Mar 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2025 is -52.91% vs 342.35% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2025 is 18.68% vs 26.47% in Mar 2025

stock-summary

Interest

QoQ Growth in quarter ended Jun 2025 is 0.00% vs -8.57% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025

Compare Quarterly Results Of Amedisys, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
621.86
232.09
389.77
167.94%
Other Operating Income
0.00
0.00
0.00
Total Operating income
621.86
232.09
389.77
167.94%
Raw Material Cost
352.84
81.20
271.64
334.53%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
130.32
0.00
130.32
Power Cost
0
0
0.00
Manufacturing Expenses
6.42
0.98
5.44
555.10%
Selling and Distribution Expenses
196.28
169.85
26.43
15.56%
Other Expenses
-13.67
8.65
-22.32
-258.03%
Total Expenditure (Excl Depreciation)
549.12
338.50
210.62
62.22%
Operating Profit (PBDIT) excl Other Income
72.74
-106.41
179.15
168.36%
Other Income
9.16
7.54
1.62
21.49%
Operating Profit (PBDIT)
88.60
-88.88
177.48
199.68%
Interest
6.42
0.98
5.44
555.10%
Exceptional Items
-27.16
0.00
-27.16
Gross Profit (PBDT)
269.02
150.88
118.14
78.30%
Depreciation
6.70
10.00
-3.30
-33.00%
Profit Before Tax
48.33
-99.86
148.19
148.40%
Tax
19.27
0.04
19.23
48,075.00%
Provisions and contingencies
0
0
0.00
Profit After Tax
28.08
-99.90
127.98
128.11%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
28.08
-99.90
127.98
128.11%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.97
0.00
0.97
Other related items
0.00
0.00
0.00
Consolidated Net Profit
29.05
-99.90
128.95
129.08%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
1,232.53
-305.48
1,538.01
503.47%
Earnings per share (EPS)
0.84
-0.80
1.64
205.00%
Diluted Earnings per share
0.84
-0.80
1.64
205.00%
Operating Profit Margin (Excl OI)
11.70%
-45.85%
0.00
57.55%
Gross Profit Margin
8.85%
-38.72%
0.00
47.57%
PAT Margin
4.52%
-43.04%
0.00
47.56%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 62.19 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 4.56% vs -0.55% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 5.19% vs 6.91% in Jun 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 2.91 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -52.91% vs 342.35% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -10.74% vs 140.50% in Jun 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 7.94 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 18.68% vs 26.47% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 12.62% vs 60.23% in Jun 2024

Quarterly - Interest
Interest 0.64 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 0.00% vs -8.57% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -18.99% vs 5.33% in Jun 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 11.70%
in Jun 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 has improved from Jun 2024